Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nephrology,Internal Medicine
Reference38 articles.
1. Nonsteroidal antagonists of the mineralocorticoid receptor
2. Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases
3. Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
4. Aldosterone Blockade in CKD: Emphasis on Pharmacology
5. Therapeutic approaches to diabetic nephropathy—beyond the RAS
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease;Nefrología (English Edition);2023-07
2. Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys;Annual Review of Medicine;2023-01-27
3. Clinical implications and guidelines for CKD in type 2 diabetes;Nephrology Dialysis Transplantation;2022-10-20
4. Finerenona: completando el abordaje del paciente con enfermedad renal y diabetes;Nefrología;2022-09
5. Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO‐DKD trial;European Journal of Heart Failure;2022-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3